Meta-analysis Results:
Figure 1 and Table 4 show the forest plot of the odds ratio of all-cause
death compared to Aspirin with placebo in diabetic patients using the
Random Effects Model. Figure 1 is statistically significant with a
p-value less than 0.05 under the random-effects model with CI varying
from 0.63 to 1.17. The confidence intervals slightly crossed the line of
no effect showing an insignificant combined result with an average odds
ratio of 0.86 for all-cause death among patients taking Aspirin compared
to placebo. Figure 2 and Table 5 showed the forest plot of the odds
ratio of CVS-related death compared to Aspirin with placebo using Random
Effects Model. The result is statistically significant with a p-value
less than 0.05 under the random-effects model with CI varying from 0.61
to 1.63. The confidence intervals slightly crossed the line of no
effect, showing an insignificant combined result with an average odds
ratio of 1.0032 for CVS-related deaths among patients taking Aspirin
compared to placebo. Figure 3 and Table 6 show the forest plot and
results of the odds ratio for the risk of MI compared to Aspirin with
placebo using Random Effects Model. The result is statistically
insignificant with a p-value of more than 0.05 under the random-effects
model with CI varying from 0.80 to 1.03. The confidence intervals
slightly crossed the line of no effect showing an insignificant combined
result with an average odds ratio of 0.9106 for MI risk among patients
taking Aspirin compared to placebo. Figure 4 and Table 7 show the forest
plot and results of the odds ratio for stroke risk compared to Aspirin
with placebo in diabetic patients using Random Effects Model. The given
figure is statistically insignificant with a p-value more than 0.05
under the random-effects model with CI varying from 0.79 to 1.09. The
confidence intervals slightly cross the line of no effect showing an
insignificant combined result with an average odds ratio of 0.9328 for
stroke risk among patients taking Aspirin compared to placebo. Figure 5
and Table 8 show the forest plot and result of the odds ratio for the
risk of bleeding in diabetic patients compared to Aspirin with placebo
using the Random Effects Model. The given figure is statistically
insignificant with a p-value more than 0.05 under the random-effects
model with CI varying from 0.47 to 4.34. The confidence intervals
crossing the line of no effect showed an insignificant combined result
with an average odds ratio of 1.4411 for bleeding events among diabetic
patients taking Aspirin when compared to placebo.